The imposition of tariffs by Germany on American pharmaceutical products has had a negative impact.

Several German chemical industry and pharmaceutical industry associations recently stated that the U.S. government's excessive imposition of tariffs on imported drugs will seriously impact the German and European pharmaceutical industry, and have a negative impact on U.S.-EU trade relations. The U.S. government recently announced that starting from October 1st, it will impose a 100% tariff on all imported brand-name or patented drugs. The German Chemical Industry Association issued a statement expressing "deep concern" about the U.S. actions. The CEO of the association, Wolfgang Groe Entrup, said that this is another blow to the EU and marks a new low in U.S.-EU trade relations.